99 related articles for article (PubMed ID: 7285015)
1. Repair of DNA adducts of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one in mouse tissues and its relation to tumor induction.
Abbott PJ; Crew F
Cancer Res; 1981 Oct; 41(10):4115-20. PubMed ID: 7285015
[TBL] [Abstract][Full Text] [Related]
2. Strain-specific tumorigenesis in mouse skin induced by the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, and its relation to DNA adduct formation and persistence.
Abbott PJ
Cancer Res; 1983 May; 43(5):2261-6. PubMed ID: 6831449
[TBL] [Abstract][Full Text] [Related]
3. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
Kulkarni MS; Anderson MW
Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
[TBL] [Abstract][Full Text] [Related]
4. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis.
Nakayama J; Yuspa SH; Poirier MC
Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664
[TBL] [Abstract][Full Text] [Related]
5. DNA adducts of the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, in vivo and in vitro: high pressure liquid chromatographic separation and partial characterization.
Abbott PJ; Coombs MM
Carcinogenesis; 1981; 2(7):629-36. PubMed ID: 7273342
[TBL] [Abstract][Full Text] [Related]
6. Identification of the proximate and ultimate forms of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one.
Coombs MM; Kissonerghis AM; Allen JA; Vose CW
Cancer Res; 1979 Oct; 39(10):4160-5. PubMed ID: 476652
[No Abstract] [Full Text] [Related]
7. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
Dreij K; Seidel A; Jernström B
Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the metabolism and DNA binding of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one by hamster embryo cells and the human hepatoma cell line HepG2.
Bhatt TS
Carcinogenesis; 1986 Jan; 7(1):143-8. PubMed ID: 3002653
[TBL] [Abstract][Full Text] [Related]
9. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
Beland FA
Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
[TBL] [Abstract][Full Text] [Related]
10. Detection of in vivo DNA repair synthesis in mouse liver and lung induced by treatment with benzo(a)pyrene or 4-nitroquinoline 1-oxide.
Kulkarni MS; Angerman-Stewart J; Anderson MW
Cancer Res; 1984 Apr; 44(4):1547-50. PubMed ID: 6322980
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the binding of some carcinogenic and non-carcinogenic cyclopenta[a]phenanthrenes to DNA in vitro and in vivo.
Russell JC; Bhatt TS; Jones JR; Coombs MM
Carcinogenesis; 1985 Aug; 6(8):1223-5. PubMed ID: 4017191
[TBL] [Abstract][Full Text] [Related]
12. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
[TBL] [Abstract][Full Text] [Related]
13. The relationship between metabolism, DNA binding, and carcinogenicity of 15,16-dihydro-11-methylcyclopenta(alpha)phenanthren-17-one in the presence of a microsomal enzyme inhibitor.
Coombs MM; Bhatt TS; Vose CW
Cancer Res; 1975 Feb; 35(2):305-9. PubMed ID: 234032
[TBL] [Abstract][Full Text] [Related]
14. Covalent DNA adducts formed by benzo[c]chrysene in mouse epidermis and by benzo[c]chrysene fjord-region diol epoxides reacted with DNA and polynucleotides.
Giles AS; Seidel A; Phillips DH
Chem Res Toxicol; 1997 Nov; 10(11):1275-84. PubMed ID: 9403182
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic and carcinogenic metabolites of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one.
Coombs MM; Bhatt TS; Kissonerghis AM; Vose CW
Cancer Res; 1980 Mar; 40(3):882-6. PubMed ID: 7471101
[TBL] [Abstract][Full Text] [Related]
16. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
18. Formation and repair of DNA adducts in vinyl chloride- and vinyl fluoride-induced carcinogenesis.
Swenberg JA; Bogdanffy MS; Ham A; Holt S; Kim A; Morinello EJ; Ranasinghe A; Scheller N; Upton PB
IARC Sci Publ; 1999; (150):29-43. PubMed ID: 10626206
[TBL] [Abstract][Full Text] [Related]
19. Chronic, topical administration of 4-aminobiphenyl induces tissue-specific DNA adducts in mice.
Underwood PM; Zhou Q; Jaeger M; Reilman R; Pinney S; Warshawsky D; Talaska G
Toxicol Appl Pharmacol; 1997 Jun; 144(2):325-31. PubMed ID: 9194416
[TBL] [Abstract][Full Text] [Related]
20. Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents.
Izzotti A; Camoirano A; Cartiglia C; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S
Cancer Res; 1999 Sep; 59(17):4285-90. PubMed ID: 10485473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
